Acrivon Therapeutics Inc. Insider Trading
ACRV
Insiders bought 115K and sold 46K on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan.
Get an email when ACRV's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 17 | Katharine Peterson Chief Accounting Officer | SoldNo plan | 107 | $1.45 | $155 | 0.6% | Form 4 |
| Nov 17 | Mary Miller Chief Legal Officer | SoldNo plan | 193 | $1.45 | $280 | 0.2% | Form 4 |
| Nov 17 | Erick Gamelin Chief Development Officer | SoldNo plan | 416 | $1.45 | $603 | 0.8% | Form 4 |
| Nov 17 | Eric Devroe Chief Operating Officer | SoldNo plan | 628 | $1.45 | $911 | 0.4% | Form 4 |
| Nov 17 | Peter Blume-Jensen President and CEO | SoldNo plan 2 parts | 1,780 | $1.45 average | 3K | <0.1% | Form 4 |
| Oct 22 | Mary Miller Chief Legal Officer | SoldNo plan | 513 | $1.84 | $944 | 0.6% | Form 4 |
| Oct 5 | Mary Miller Chief Legal Officer | SoldNo plan | 294 | $1.99 | $585 | 0.4% | Form 4 |
| Aug 25 | Peter Blume-Jensen President and CEO | SoldNo plan | 14,036 | $2.21 | 31K | 0.5% | Form 4 |
| Aug 18 | Katharine Peterson Chief Accounting Officer | SoldNo plan | 101 | $2.01 | $203 | 0.6% | Form 4 |
| Aug 18 | Mary Miller Chief Legal Officer | SoldNo plan | 185 | $2.01 | $372 | 0.2% | Form 4 |
| Aug 18 | Erick Gamelin Chief Development Officer | SoldNo plan | 400 | $2.01 | $804 | 0.8% | Form 4 |
| Aug 18 | Eric Devroe Chief Operating Officer | SoldNo plan | 604 | $2.01 | 1K | 0.4% | Form 4 |
| Aug 18 | Kristina Masson EVP - Business Operations | SoldNo plan 2 parts | 1,713 | $2.01 average | 3K | <0.1% | Form 4 |
| Aug 4 | Adam D. Levy Chief Financial Officer | SoldNo plan | 1,142 | $1.57 | 2K | 1.7% | Form 4 |
| Jul 21 | Mary Miller Chief Legal Officer | SoldNo plan | 573 | $1.76 | 1K | 0.7% | Form 4 |
| Jan 14 | Peter Blume-Jensen President and CEO | Bought | 49,000 | $1.68 | 82K | 2.1% | Form 4 |
| Jan 14 | Adam D. Levy Chief Financial Officer | Bought | 8,832 | $1.70 | 15K | 73% | Form 4 |
| Jan 13 | Eric Devroe Chief Operating Officer | Bought | 10,000 | $1.72 | 17K | 15% | Form 4 |
| Apr 30, 2025 – May 1, 2025 | Perceptive Advisors LLC Large holder | SoldNo plan 2 parts | 736,767 | $1.38 average | $1.02M | 19% | Form 4 |
| Apr 25, 2025 – Apr 29, 2025 | Perceptive Advisors LLC Large holder | SoldNo plan 3 parts | 1,519,952 | $1.81 average | $2.74M | 28% | Form 4 |
- Nov 17No planKatharine PetersonChief Accounting Officer · sold 107 at $1.45$1550.6% of stake
- Nov 17No planMary MillerChief Legal Officer · sold 193 at $1.45$2800.2% of stake
- Nov 17No planErick GamelinChief Development Officer · sold 416 at $1.45$6030.8% of stake
- Nov 17No planEric DevroeChief Operating Officer · sold 628 at $1.45$9110.4% of stake
- Nov 17No planPeter Blume-JensenPresident and CEO · sold 1,780 at avg $1.453K<0.1% of stake
- Oct 22No planMary MillerChief Legal Officer · sold 513 at $1.84$9440.6% of stake
- Oct 5No planMary MillerChief Legal Officer · sold 294 at $1.99$5850.4% of stake
- Aug 25No planPeter Blume-JensenPresident and CEO · sold 14,036 at $2.2131K0.5% of stake
- Aug 18No planKatharine PetersonChief Accounting Officer · sold 101 at $2.01$2030.6% of stake
- Aug 18No planMary MillerChief Legal Officer · sold 185 at $2.01$3720.2% of stake
- Aug 18No planErick GamelinChief Development Officer · sold 400 at $2.01$8040.8% of stake
- Aug 18No planEric DevroeChief Operating Officer · sold 604 at $2.011K0.4% of stake
- Aug 18No planKristina MassonEVP - Business Operations · sold 1,713 at avg $2.013K<0.1% of stake
- Aug 4No planAdam D. LevyChief Financial Officer · sold 1,142 at $1.572K1.7% of stake
- Jul 21No planMary MillerChief Legal Officer · sold 573 at $1.761K0.7% of stake
- Jan 14Peter Blume-JensenPresident and CEO · bought 49,000 at $1.6882K2.1% of stake
- Jan 14Adam D. LevyChief Financial Officer · bought 8,832 at $1.7015K73% of stake
- Jan 13Eric DevroeChief Operating Officer · bought 10,000 at $1.7217K15% of stake
- Apr 30, 2025 – May 1, 2025No planPerceptive Advisors LLCLarge holder · sold 736,767 at avg $1.38$1.02M19% of stake
- Apr 25, 2025 – Apr 29, 2025No planPerceptive Advisors LLCLarge holder · sold 1,519,952 at avg $1.81$2.74M28% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with ACRV
Spot a number that looks wrong? Check it in ACRV's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ACRV
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.